[Previous Months][Date Index][Thread Index][Join - Register][Login]
  [Message Prev][Message Next][Thread Prev][Thread Next]

[IP] Deltec, Inc. Receives 510k Clearance for Insulin Pump

 <A HREF="http://www.businesswire.com/cgi-bin/f_headline.cgi?day0/222272277&ticker=">Deltec, Inc. Receives 510k Clearance for Insulin Pump</A> 

BW2277  AUG 15,2002       9:01 PACIFIC      12:01 EASTERN

( BW)(MN-DELTEC) Deltec, Inc. Receives 510k Clearance for Insulin Pump

    Business Editors & Health/Medical Writers

    ST. PAUL, Minn.--(BW HealthWire)--Aug. 15, 2002--Deltec, Inc., the 
Minnesota-based infusion pump manufacturer, part of Smiths Medical, has 
received 510k clearance from the Food and Drug Administration (FDA) to allow 
it to market its insulin infusion pump in the treatment of diabetes.
    The new Deltec Cozmo(TM) insulin pump offers significant advantages over 
currently available insulin pumps, most notably its ease of use and flexible 
programming which allow people with diabetes to personalize their treatment 
to meet their lifestyle demands. It is estimated that approx. six per cent of 
the U.S. population has diabetes.
    The pump is a small, lightweight, cell phone-size device worn by a person 
with diabetes to deliver insulin continuously, day and night through a small, 
short, flexible plastic tube that is inserted just under the skin and changed 
every few days. Patient friendly features including a full-sized 300 unit 
insulin cartridge, power by a single AAA battery, and a large, easy to read 
display, are combined with over twenty years of Deltec's ambulatory pump 
development and manufacturing experience.
    "Deltec has a long history of developing high quality, reliable 
ambulatory infusion pumps," said Jim Stitt, president of Deltec, "and we have 
combined that expertise with the needs identified from people with diabetes, 
certified diabetes educators, and physicians to develop a superior insulin 
    The Deltec Cozmo(TM) insulin pump also has many safety features that are 
designed with pediatric use in mind, such as a Program Lockout that prevents 
users from entering the menu, a Delivery Limit Alarm to limit the amount of 
insulin that is delivered over an hour, and a Missed Meal Bolus Alert that 
alerts the user if a meal bolus is not given.
    Deltec has sold over 150,000 ambulatory infusion pumps worldwide, which 
are used in a variety of infusion therapies to deliver medications for 
chemotherapy, pain management, TPN, hydration, dialysis, and to deliver 
antibiotics, treat primary pulmonary hypertension, eliminate excess iron, 
prevent clotting, and produce blood cells. The ambulatory nature of Deltec 
infusion pumps allows patients to maintain a better quality of life while 
undergoing their therapy.
    Headquartered in St. Paul, MN, Deltec is part of the Medical division of 
Smiths Group plc, London and manufactures a wide range of infusion and access 
systems for domestic and international markets. For additional information, 
visit Deltec's web site at <A HREF="http://www.deltec.com/">www.deltec.com</A>.

    --30--cr/ms*CONTACT: Deltec, Inc., St. PaulTerri Servais, 
651/628-7248E-mail: <A HREF="mailto:email @ redacted">email @ redacted</A>orBrian Johnson, 
651/628-7154E-mail: <A HREF="mailto:email @ redacted">email @ redacted</A>KEYWORD: MINNESOTA UNITED KINGDOM 
for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml